LNA-anti-miR-21 was shown to increase the treatment efficacy of a secreted variant of the cytotoxic agent Secretable form of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (S-TRAIL) on glioma. This evidence concerns the gene TNFSF10 and glioma.